Literature DB >> 32021746

Calcified Prolactinoma of the Pituitary Gland: Illustrative Case Reports Highlighting Medical versus Surgical Intervention.

Sherwin Tavakol1, Asma Hasan2, Michelle A Wedemeyer1, Joshua Bakhsheshian1, Chia-Shang J Liu3, Mark S Shiroishi3, Anna Mathew4, John D Carmichael2, Gabriel Zada1.   

Abstract

The presence of calcification is uncommon in pituitary adenomas, and often lends support to other diagnoses including craniopharyngioma. The majority of calcified pituitary adenomas are prolactin-secreting tumors. We report two patients with calcified macroprolactinomas, one that was treated medically with a biochemical response and partial tumor response, and one that was treated successfully via an endoscopic endonasal transsphenoidal approach. Suspected calcified prolactinomas can be initially managed medically as per standard treatment for typical prolactinomas; however, the presence of diffuse calcification may hinder tumor shrinkage. Tumors that are refractory to medical treatment can be safely managed with surgery. © Thieme Medical Publishers.

Entities:  

Keywords:  Rathke's; amyloid; calcified prolactinoma; pituitary adenoma; prolactin; sella; turcica

Year:  2019        PMID: 32021746      PMCID: PMC6996997          DOI: 10.1055/s-0039-1677678

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  39 in total

Review 1.  Pharmacologic resistance in prolactinoma patients.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  MR imaging characteristics of amyloid deposits in pituitary adenoma.

Authors:  Steven W Martin; Daniel R Lefton; Richard S Pinto; Marc Rosenblum; Eric Elowitz
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

3.  Calcified pituitary adenoma associated with severe hyperprolactinemia. Case report.

Authors:  C M Carapella; P Pompei; R Mastrostefano; E Occhipinti; A Rocco; P Falaschi
Journal:  J Neurosurg       Date:  1983-11       Impact factor: 5.115

Review 4.  Advances in the treatment of prolactinomas.

Authors:  Mary P Gillam; Mark E Molitch; Gaetano Lombardi; Annamaria Colao
Journal:  Endocr Rev       Date:  2006-05-26       Impact factor: 19.871

5.  Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.

Authors:  A Di Sarno; M L Landi; P Cappabianca; F Di Salle; F W Rossi; R Pivonello; C Di Somma; A Faggiano; G Lombardi; A Colao
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

6.  Ossified prolactinoma: case report.

Authors:  K Mukada; M Ohta; T Uozumi; K Arita; K Kurisu; K Inai
Journal:  Neurosurgery       Date:  1987-03       Impact factor: 4.654

7.  Squash smear findings of spherical amyloid in pituitary prolactinoma. A case report.

Authors:  Se Hoon Kim; Sun Ho Kim; Seung-Koo Lee; Tai Seung Kim
Journal:  Acta Cytol       Date:  2004 May-Jun       Impact factor: 2.319

8.  Resistance to bromocriptine in prolactinomas.

Authors:  I Pellegrini; R Rasolonjanahary; G Gunz; P Bertrand; S Delivet; C P Jedynak; C Kordon; F Peillon; P Jaquet; A Enjalbert
Journal:  J Clin Endocrinol Metab       Date:  1989-09       Impact factor: 5.958

9.  Calcified pituitary prolactinoma.

Authors:  S Phansey; J M Powers; J Sagel; G D Hungerford; S E Rawe; H O Williamson
Journal:  Obstet Gynecol       Date:  1981-06       Impact factor: 7.661

10.  Calcifications in pituitary adenomas.

Authors:  B Rilliet; G Mohr; F Robert; J Hardy
Journal:  Surg Neurol       Date:  1981-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.